Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-067067)

Filing Details

Accession Number:: 0001209191-21-067067
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-29 21:47:46
Reporting Period:: 2021-11-24

Accepted Time:: 2021-11-29 21:47:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614740	Christopher Peetz	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-24	7,000	$14.40	28,027	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	201,570	Indirect	By The Peetz Family Trust

Footnotes

The Reporting Person's purchase of MIRM common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 3,672 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transaction resulted in short-swing profits of $17,831.23 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.